| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 396 | 2010 |
| A consensus on the diagnosis and treatment of acromegaly comorbidities: an update A Giustina, A Barkan, A Beckers, N Biermasz, BMK Biller, C Boguszewski, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e937-e946, 2020 | 279 | 2020 |
| Mechanisms in endocrinology: Ghrelin: the differences between acyl-and des-acyl ghrelin PJD Delhanty, SJ Neggers, AJ Van der Lely European journal of endocrinology 167 (5), 601-608, 2012 | 270 | 2012 |
| Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database P Petrossians, AF Daly, E Natchev, L Maione, K Blijdorp, ... Endocrine-related cancer 24 (10), 505, 2017 | 239 | 2017 |
| Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late … W Van Dorp, RL Mulder, LCM Kremer, MM Hudson, ... Journal of Clinical Oncology 34 (28), 3440, 2016 | 218 | 2016 |
| Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy JC Teepen, FE van Leeuwen, WJ Tissing, E van Dulmen-den Broeder, ... Journal of Clinical Oncology 35 (20), 2288-2298, 2017 | 212 | 2017 |
| Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant S Neggers, MO Van Aken, WW De Herder, RA Feelders, J Janssen, ... The Journal of Clinical Endocrinology & Metabolism 93 (10), 3853-3859, 2008 | 201 | 2008 |
| Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood … R Skinner, RL Mulder, LC Kremer, MM Hudson, LS Constine, E Bardi, ... The Lancet Oncology 18 (2), e75-e90, 2017 | 197 | 2017 |
| Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients L Rostomyan, AF Daly, P Petrossians, E Nachev, AR Lila, AL Lecoq, ... Endocrine-related cancer 22 (5), 745-757, 2015 | 186 | 2015 |
| X-linked acrogigantism syndrome: clinical profile and therapeutic responses A Beckers, MB Lodish, G Trivellin, L Rostomyan, M Lee, FR Faucz, ... Endocrine-related cancer 22 (3), 353-367, 2015 | 179 | 2015 |
| Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly SJ Neggers, MO van Aken, JA Janssen, RA Feelders, WW de Herder, ... The Journal of Clinical Endocrinology & Metabolism 92 (12), 4598-4601, 2007 | 177 | 2007 |
| Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly F Gatto, RA Feelders, R van der Pas, JM Kros, M Waaijers, D Sprij-Mooij, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E66-E71, 2013 | 169 | 2013 |
| Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly F Gatto, RA Feelders, R van der Pas, JM Kros, M Waaijers, D Sprij-Mooij, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), E66-E71, 2013 | 169 | 2013 |
| Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review SC Clement, RP Peeters, CM Ronckers, TP Links, ... Cancer treatment reviews 41 (10), 925-934, 2015 | 163 | 2015 |
| Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer M van Waas, S Neggers, R Pieters, MM van den Heuvel-Eibrink Annals of oncology 21 (5), 1121-1126, 2010 | 136 | 2010 |
| Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late … SC Clement, LCM Kremer, FA Verburg, JH Simmons, M Goldfarb, ... Cancer treatment reviews 63, 28-39, 2018 | 134 | 2018 |
| Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients S Neggers, WW De Herder, J Janssen, RA Feelders, AJ van der Lely European Journal of Endocrinology 160 (4), 529-533, 2009 | 133 | 2009 |
| Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly S Neggers, SE Franck, FWM De Rooij, AHG Dallenga, RML Poublon, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), 3644-3652, 2014 | 129 | 2014 |
| Des-acyl ghrelin: a metabolically active peptide PJ Delhanty, SJ Neggers, AJ van der Lely The Ghrelin System 25, 112-121, 2013 | 128 | 2013 |
| Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late … RL Mulder, A Font-Gonzalez, MM Hudson, HM Van Santen, EAH Loeffen, ... The Lancet Oncology 22 (2), e45-e56, 2021 | 127 | 2021 |
AJ van der LelyHoogleraar Endocrinologie, Erasmus University MCVerified email at erasmusmc.nl
